Healthcare Industry News Weekly Wrap-Up: March 3, 2023
// Biotech and Pharma Therapeutics After spending $6.5B for Momenta, J&J readies ‘pipeline in a product’ for pivotal year February 27, 2023 / Janssen Pharma / Myasthenia Gravis / Rheumatoid Arthritis / Neurology With over 10 indications already being explored...
